BRPI0416411A - uso de deoxipeganina - Google Patents
uso de deoxipeganinaInfo
- Publication number
- BRPI0416411A BRPI0416411A BRPI0416411-3A BRPI0416411A BRPI0416411A BR PI0416411 A BRPI0416411 A BR PI0416411A BR PI0416411 A BRPI0416411 A BR PI0416411A BR PI0416411 A BRPI0416411 A BR PI0416411A
- Authority
- BR
- Brazil
- Prior art keywords
- deoxipeganine
- deoxypeganine
- derivative
- deoxipeganin
- acetylcholinesterase
- Prior art date
Links
- WUFQLZTXIWKION-UHFFFAOYSA-N Deoxypeganine Chemical compound C1C2=CC=CC=C2N=C2N1CCC2 WUFQLZTXIWKION-UHFFFAOYSA-N 0.000 abstract 3
- 102000012440 Acetylcholinesterase Human genes 0.000 abstract 1
- 108010022752 Acetylcholinesterase Proteins 0.000 abstract 1
- VARHXCYGZKSOOO-UHFFFAOYSA-N Deoxyvasicinone Natural products C1=CC=C2C(=O)N(CCC3)C3=NC2=C1 VARHXCYGZKSOOO-UHFFFAOYSA-N 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 229940022698 acetylcholinesterase Drugs 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000000544 cholinesterase inhibitor Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000002899 monoamine oxidase inhibitor Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000000698 schizophrenic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
"USO DE DEOXIPEGANINA". Deoxipeganina na forma de uma base livre ou na forma de um sal de ácido de adição, ou de um derivado de deoxipeganina contanto que o referido derivado seja um inibidor de acetilacolinesterase e de mono amino oxidase simultaneamente, pode ser usada para a produção de um medicamento para o tratamento de uma psicose esquizofrênica.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10354893A DE10354893B4 (de) | 2003-11-24 | 2003-11-24 | Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen |
| PCT/EP2004/012605 WO2005053673A1 (de) | 2003-11-24 | 2004-11-08 | Verwendung von desoxypeganin zur behandlung schizophrener psychosen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0416411A true BRPI0416411A (pt) | 2007-01-09 |
Family
ID=34625212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0416411-3A BRPI0416411A (pt) | 2003-11-24 | 2004-11-08 | uso de deoxipeganina |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20070072947A1 (pt) |
| EP (1) | EP1725229B1 (pt) |
| JP (1) | JP2007512269A (pt) |
| KR (1) | KR20070085036A (pt) |
| CN (1) | CN1886127A (pt) |
| AR (1) | AR046664A1 (pt) |
| AT (1) | ATE424197T1 (pt) |
| AU (1) | AU2004294689B2 (pt) |
| BR (1) | BRPI0416411A (pt) |
| CA (1) | CA2547171A1 (pt) |
| DE (2) | DE10354893B4 (pt) |
| DK (1) | DK1725229T3 (pt) |
| EA (1) | EA012033B1 (pt) |
| ES (1) | ES2323645T3 (pt) |
| IL (1) | IL175772A0 (pt) |
| MY (1) | MY141730A (pt) |
| NO (1) | NO20062666L (pt) |
| NZ (1) | NZ547103A (pt) |
| SI (1) | SI1725229T1 (pt) |
| TW (1) | TW200607507A (pt) |
| UA (1) | UA86951C2 (pt) |
| WO (1) | WO2005053673A1 (pt) |
| ZA (1) | ZA200603543B (pt) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
| DE19906978B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit |
| DE19906977C1 (de) * | 1999-02-19 | 2000-06-15 | Lohmann Therapie Syst Lts | Desoxypeganin-TTS und seine Verwendung |
| DE19906975B4 (de) * | 1999-02-19 | 2004-04-15 | Lts Lohmann Therapie-Systeme Ag | Arzneiform zur Behandlung von Alzheimer'scher Demenz |
| DE19906979B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit |
| DE10119863A1 (de) * | 2001-04-24 | 2002-11-07 | Hf Arzneimittelforsch Gmbh | Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen |
| DE10134038A1 (de) * | 2001-07-12 | 2003-02-06 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit |
| DE10163667B4 (de) * | 2001-12-21 | 2006-10-26 | Hf Arzneimittelforschung Gmbh | Verwendung von Desoxypeganin zur Behandlung der klinischen Depression |
-
2003
- 2003-11-24 DE DE10354893A patent/DE10354893B4/de not_active Expired - Fee Related
-
2004
- 2004-11-08 CA CA002547171A patent/CA2547171A1/en not_active Abandoned
- 2004-11-08 NZ NZ547103A patent/NZ547103A/xx unknown
- 2004-11-08 AU AU2004294689A patent/AU2004294689B2/en not_active Ceased
- 2004-11-08 AT AT04797701T patent/ATE424197T1/de active
- 2004-11-08 CN CNA2004800347420A patent/CN1886127A/zh active Pending
- 2004-11-08 SI SI200431129T patent/SI1725229T1/sl unknown
- 2004-11-08 EA EA200601016A patent/EA012033B1/ru not_active IP Right Cessation
- 2004-11-08 BR BRPI0416411-3A patent/BRPI0416411A/pt not_active Application Discontinuation
- 2004-11-08 DK DK04797701T patent/DK1725229T3/da active
- 2004-11-08 ES ES04797701T patent/ES2323645T3/es not_active Expired - Lifetime
- 2004-11-08 WO PCT/EP2004/012605 patent/WO2005053673A1/de not_active Ceased
- 2004-11-08 KR KR1020067010132A patent/KR20070085036A/ko not_active Ceased
- 2004-11-08 DE DE502004009105T patent/DE502004009105D1/de not_active Expired - Lifetime
- 2004-11-08 EP EP04797701A patent/EP1725229B1/de not_active Expired - Lifetime
- 2004-11-08 US US10/580,443 patent/US20070072947A1/en not_active Abandoned
- 2004-11-08 UA UAA200605674A patent/UA86951C2/ru unknown
- 2004-11-08 JP JP2006540235A patent/JP2007512269A/ja active Pending
- 2004-11-18 MY MYPI20044782A patent/MY141730A/en unknown
- 2004-11-19 TW TW093135601A patent/TW200607507A/zh unknown
- 2004-11-24 AR ARP040104344A patent/AR046664A1/es unknown
-
2006
- 2006-05-05 ZA ZA200603543A patent/ZA200603543B/xx unknown
- 2006-05-18 IL IL175772A patent/IL175772A0/en unknown
- 2006-06-09 NO NO20062666A patent/NO20062666L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070085036A (ko) | 2007-08-27 |
| DE10354893B4 (de) | 2011-03-10 |
| JP2007512269A (ja) | 2007-05-17 |
| CN1886127A (zh) | 2006-12-27 |
| MY141730A (en) | 2010-06-15 |
| EP1725229A1 (de) | 2006-11-29 |
| AU2004294689A1 (en) | 2005-06-16 |
| ES2323645T3 (es) | 2009-07-22 |
| UA86951C2 (ru) | 2009-06-10 |
| AR046664A1 (es) | 2005-12-14 |
| CA2547171A1 (en) | 2005-06-16 |
| AU2004294689B2 (en) | 2010-01-07 |
| IL175772A0 (en) | 2008-04-13 |
| EA012033B1 (ru) | 2009-06-30 |
| HK1093696A1 (zh) | 2007-03-09 |
| DK1725229T3 (da) | 2009-06-22 |
| ZA200603543B (en) | 2007-03-28 |
| ATE424197T1 (de) | 2009-03-15 |
| EP1725229B1 (de) | 2009-03-04 |
| DE10354893A1 (de) | 2005-06-30 |
| EA200601016A1 (ru) | 2006-10-27 |
| NZ547103A (en) | 2009-07-31 |
| NO20062666L (no) | 2006-06-09 |
| TW200607507A (en) | 2006-03-01 |
| SI1725229T1 (sl) | 2009-08-31 |
| WO2005053673A1 (de) | 2005-06-16 |
| DE502004009105D1 (de) | 2009-04-16 |
| US20070072947A1 (en) | 2007-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28314A1 (es) | Preparacion y uso de derivados de alquilarilo para el tratamiento de la obesidad | |
| NO20071042L (no) | 5-substituerte 2-fenylaminobenzamider som MEK-inhibitorer | |
| UY29919A1 (es) | Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones | |
| MA29856B1 (fr) | Derives de diacylindazole en tant qu'inhibiteurs de lipases et de phospholipases | |
| BRPI0409227A (pt) | composto, composição farmacêutica, uso de um composto, intermediário, e, processo para a preparação de um composto | |
| AR087241A2 (es) | Derivados de 6-oh-4h-benzo[1,4]oxazin-3-ona para el tratamiento de la enfermedad pulmonar obstructiva cronica | |
| BR0309343A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
| CY1109722T1 (el) | Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole | |
| CY1111170T1 (el) | Ενωσεις διαρυλ αιθερα ουριας | |
| BR0314096A (pt) | Processo para a preparação de uma composição pesticida seca contendo um sal solúvel em água de ácido glifosato e um componente dicarboxilato | |
| BRPI0409624A (pt) | 2-hidróxi-3-diaminoalcanos de benzamida | |
| ATE365740T1 (de) | Substituierte pyrazolopyrimidine | |
| BRPI0409627A (pt) | 2-hidróxi-3-diaminoalcanos de fenacila | |
| BRPI0407662A (pt) | derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas | |
| BR0309342A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
| IS8485A (is) | Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki | |
| BR0211118A (pt) | Composto, métodos para o tratamento ou prevenção de doenças e para fabricar um composto, intermediário, e, uso de um composto ou sal | |
| BR0213760A (pt) | Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição | |
| BRPI0518231A2 (pt) | derivados de 2-amido-4-feniltiazol, o respectivo preparo e a respectiva aplicaÇço em terapÊutica | |
| UY27825A1 (es) | Derivados de n-acilamino bencil eter | |
| BR0317284A (pt) | Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno | |
| HUP0202881A2 (hu) | Antisztatikum | |
| ECSP055844A (es) | Nuevos compuestos triciclicos | |
| BR0315055A (pt) | Diamidas de ácido pirimidin-4,6-dicarboxìilco para a inibição seletiva de colagenases | |
| BR0314180A (pt) | Aminoéteres substituìdos para o tratamento da doença de alzheimer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: PARA:INT.CI. A61K 31/33, A61K 35/78, A61P 25/18 Ipc: A61K 31/33 (2011.01), A61K 35/78 (00000007), A61P |
|
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 31/33; A61K 35/78; A61P 25/18. Ipc: A61K 31/33 (2006.01) Ipc: A61K 31/33 (2006.01) |
|
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |